michigan semaglutide bowel obstruction lawsuit digestive blockage class action gastrointestinal Subocclusive ileus following off-label high-dose semaglutide use in: Endocrinology, Diabetes & Metabolism Case Reports Volume 2025 Issue 4 (2025) filed against GLP-1 receptor agonists may cause

Englund A, Lange AH, Hagemann CA, et al

The study found that 76 in 100 people had coverage for GLP-1 agonists if they had diabetes, while 27 in 100 individuals had coverage for GLP-1 agonists for weight loss alone

For instance, peptides or proteins mimicking the SOCS box could be developed

GLP-1 Medications: The Foundation of Medical Weight Loss GLP-1 (glucagon-like peptide-1) medications were the first breakthrough in hormone-based weight loss and remain widely used

I love to take strawberry core power shakes and blend it with frozen strawberries, bananas, Greek yogurt (for even more protein) and chia seeds, Moody said